Abstract
This Viewpoint discusses potential blind spots and opportunities for advancement in current clinical high risk for psychosis research and corollary implications for the clinical validity of DSM-5 attenuated psychosis syndrome.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
